Joel Greenblatt Ironwood Pharmaceuticals Inc Transaction History

Gotham Asset Management, LLC

$7.56 Billion
Q2 2024

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Gotham Asset Management, LLC holds 60,160 shares of IRWD stock, worth $287,564. This represents 0.01% of its overall portfolio holdings.

Number of Shares

60,160

Previous 73,954 18.65%

Holding current value

$287,564

Previous $644,000 39.13%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.58 - $8.61 $76,970 - $118,766	-13,794 Reduced 18.65%	60,160 $392,000
Q1 2024 May 15, 2024	BUY	$8.32 - $15.45 $99,032 - $183,901	11,903 Added 19.18%	73,954 $644,000
Q4 2023 Feb 14, 2024	BUY	$8.79 - $11.51 $357,506 - $468,134	40,672 Added 190.24%	62,051 $709,000
Q3 2023 Nov 14, 2023	SELL	$8.25 - $11.35 $591,219 - $813,375	-71,663 Reduced 77.02%	21,379 $205,000
Q2 2023 Aug 14, 2023	SELL	$10.1 - $11.6 $190,051 - $218,277	-18,817 Reduced 16.82%	93,042 $989,000
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $378,888 - $458,904	36,537 Added 48.51%	111,859 $1.18 Million
Q4 2022 Feb 14, 2023	SELL	$9.9 - $12.43 $368,676 - $462,893	-37,240 Reduced 33.08%	75,322 $933,000
Q3 2022 Nov 14, 2022	BUY	$10.14 - $12.38 $692,024 - $844,897	68,247 Added 154.0%	112,562 $1.17 Million
Q2 2022 Aug 15, 2022	SELL	$11.05 - $12.72 $515,714 - $593,655	-46,671 Reduced 51.29%	44,315 $511,000
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $1.03 Million - $1.25 Million	-96,666 Reduced 51.51%	90,986 $1.15 Million
Q4 2021 Feb 14, 2022	BUY	$10.86 - $13.95 $842,540 - $1.08 Million	77,582 Added 70.48%	187,652 $2.19 Million
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $184,044 - $214,924	15,440 Added 16.32%	110,070 $1.44 Million
Q2 2021 Aug 16, 2021	BUY	$10.16 - $13.11 $774,120 - $998,890	76,193 Added 413.26%	94,630 $1.22 Million
Q1 2021 May 17, 2021	BUY	$9.04 - $11.86 $16,950 - $22,237	1,875 Added 11.32%	18,437 $206,000
Q4 2020 Feb 16, 2021	SELL	$9.05 - $12.2 $345,691 - $466,015	-38,198 Reduced 69.76%	16,562 $189,000
Q3 2020 Nov 16, 2020	BUY	$8.99 - $10.74 $80,163 - $95,768	8,917 Added 19.45%	54,760 $493,000
Q2 2020 Aug 13, 2020	SELL	$9.14 - $11.97 $323,053 - $423,079	-35,345 Reduced 43.53%	45,843 $473,000
Q1 2020 May 15, 2020	SELL	$8.58 - $14.01 $311,316 - $508,338	-36,284 Reduced 30.89%	81,188 $819,000
Q4 2019 Feb 14, 2020	BUY	$8.22 - $14.0 $707,824 - $1.21 Million	86,110 Added 274.57%	117,472 $1.56 Million
Q3 2019 Nov 14, 2019	BUY	$8.59 - $10.96 $17,746 - $22,643	2,066 Added 7.05%	31,362 $269,000
Q2 2019 Aug 14, 2019	SELL	$9.8 - $12.89 $204,545 - $269,040	-20,872 Reduced 41.6%	29,296 $320,000
Q1 2019 May 15, 2019	BUY	$8.27 - $12.73 $306,792 - $472,244	37,097 Added 283.81%	50,168 $679,000
Q4 2018 Feb 14, 2019	BUY	$7.8 - $16.13 $101,953 - $210,835	13,071 New	13,071 $135,000
Q4 2017 Feb 14, 2018	SELL	$12.16 - $14.58 $417,258 - $500,298	-34,314 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.07 - $14.87 $414,169 - $510,249	34,314	34,314 $541,000

Others Institutions Holding IRWD

# of Institutions

244

Shares Held

168M

Call Options Held

11.2M

Put Options Held

28.5K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $732M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account